Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients. In some hepatitis C virus-infected patients, PEG-IFN plus RBV treatment against HCV s...
| 出版年: | Journal of Nepal Medical Association |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nepal Medical Association
2011-03-01
|
| オンライン･アクセス: | http://jnma.com.np/jnma/index.php/jnma/article/view/44 |